Home >> Pharmaceuticals >> Food & Beverage >>

Global Antihistamine Drugs Detailed Analysis Report 2017-2022

Published: Sep-2017 | Format: PDF | Detailed Analysis Research | Number of pages: 110 | Code: MRS - 180200

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Antihistamine Drugs industry.

This report splits Antihistamine Drugs market By Antihistanmines, By Access, which covers the history data information from 2012 to 2016 and forecast from 2017 to 2022.

This report focuses Global market, it covers details as following:

Major Companies

  • Akorn Pharmaceuticals (US)
  • Almirall S.A. (Spain)
  • Auctus Pharma Limited (India)
  • Bayer SA-NV (Belgium)
  • Kyowa Hakko Kirin Co.,Ltd. (Japan)
  • MEDA Pharma GmbH & Co. KG (Germany)
  • Merck Sharp & Dohme Limited (UK)
  • Nippon Boehringer Ingelheim Co.,Ltd. (Japan)
  • Pfizer Pharmaceutical Company (US)
  • Sanofi Winthrop Industries (France)
  • Santen Pharmaceutical Co.,Ltd. (Japan)
  • Schering-Plough Europe (US)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Teva Pharmaceutical Industries (Israel)
  • Therabel Europe Limited (Ireland)
  • UCB Pharma GmbH (Germany)
  • Vintage Pharmaceuticals (US)

Main Regions

  • North America
  • United States
  • Canada
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Netherland
  • Others
  • Asia & Pacific
  • China
  • Japan
  • India
  • Korea
  • Australia
  • Southeast Asia
  • Indonesia
  • Thailand
  • Philippines
  • Vietnam
  • Singapore
  • Malaysia
  • Others
  • Africa & Middle East
  • South Africa
  • Egypt
  • Turkey
  • Saudi Arabia
  • Iran
  • Others

Main Product Type

  • Antihistamine Drugs Market, by Antihistanmines
  • Azelastine
  • Brompheniramine
  • Carbinoxamine
  • Cetirizine
  • Other
  • Antihistamine Drugs Market, by Access
  • Prescription
  • OTC

Main Applications

  • Department of respiration
  • Otolaryngology
  • Department of dermatology
  • Pharmacy

Table of Contents

Global Antihistamine Drugs Detailed Analysis Report 2017-2022
Chapter One Antihistamine Drugs Market Overview
    1.1 Global Antihistamine Drugs Market Sales Volume Revenue and Price 2012-2022
    1.2 Antihistamine Drugs, By Antihistanmines 2012-2022
        1.2.1 Global Antihistamine Drugs Sales Market Share by Antihistanmines 2012-2022
        1.2.2 Global Antihistamine Drugs Revenue Market Share by Antihistanmines 2012-2022
        1.2.3 Global Antihistamine Drugs Price by Antihistanmines 2012-2022
        1.2.4 Azelastine
        1.2.5 Brompheniramine
        1.2.6 Carbinoxamine
        1.2.7 Cetirizine
        1.2.8 Other
    1.3 Antihistamine Drugs, by Access 2012-2022
        1.3.1 Global Antihistamine Drugs Sales Market Share by Access 2012-2022
        1.3.2 Global Antihistamine Drugs Revenue Market Share by Access 2012-2022
        1.3.3 Global Antihistamine Drugs Price by Access 2012-2022
        1.3.4 Prescription
        1.3.5 OTC

Chapter Two Antihistamine Drugs by Regions 2012-2017
    2.1 Global Antihistamine Drugs Sales Market Share by Regions 2012-2017
    2.2 Global Antihistamine Drugs Revenue Market Share by Regions 2012-2017
    2.3 Global Antihistamine Drugs Price by Regions 2012-2017
    2.4 North America
        2.4.1 United States
        2.4.2 Canada
    2.5 Latin America
        2.5.1 Mexico
        2.5.2 Brazil
        2.5.3 Argentina
        2.5.4 Others in Latin America
    2.6 Europe
        2.6.1 Germany
        2.6.2 United Kingdom
        2.6.3 France
        2.6.4 Italy
        2.6.5 Spain
        2.6.6 Russia
        2.6.7 Netherland
        2.6.8 Others in Europe
    2.7 Asia & Pacific
        2.7.1 China
        2.7.2 Japan
        2.7.3 India
        2.7.4 Korea
        2.7.5 Australia
        2.7.6 Southeast Asia
            2.7.6.1 Indonesia
            2.7.6.2 Thailand
            2.7.6.3 Philippines
            2.7.6.4 Vietnam
            2.7.6.5 Singapore
            2.7.6.6 Malaysia
            2.7.6.7 Others in Southeast Asia
    2.8 Africa & Middle East
        2.8.1 South Africa
        2.8.2 Egypt
        2.8.3 Turkey
        2.8.4 Saudi Arabia
        2.8.5 Iran
        2.8.6 Others in Africa & Middle East

Chapter Three Antihistamine Drugs by Players 2012-2017
    3.1 Global Antihistamine Drugs Sales Volume Market Share by Players 2012-2017
    3.2 Global Antihistamine Drugs Revenue Share by Players 2012-2017
    3.3 Global Top Players Antihistamine Drugs Key Product Model and Market Performance
    3.4 Global Top Players Antihistamine Drugs Key Target Consumers and Market Performance

Chapter Four Antihistamine Drugs by Consumer 2012-2017
    4.1 Global Antihistamine Drugs Sales Market Share by Consumer 2012-2017
    4.2 Department of respiration
    4.3 Otolaryngology
    4.4 Department of dermatology
    4.5 Pharmacy
    4.6 Consuming Habit and Preference

Chapter Five Global Top Players Profile
    5.1 Akorn Pharmaceuticals (US)
        5.1.1 Akorn Pharmaceuticals (US) Company Details and Competitors
        5.1.2 Akorn Pharmaceuticals (US) Key Antihistamine Drugs Models and Performance
        5.1.3 Akorn Pharmaceuticals (US) Antihistamine Drugs Business SWOT Analysis and Forecast
        5.1.4 Akorn Pharmaceuticals (US) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
    5.2 Almirall S.A. (Spain)
        5.2.1 Almirall S.A. (Spain) Company Details and Competitors
        5.2.2 Almirall S.A. (Spain) Key Antihistamine Drugs Models and Performance
        5.2.3 Almirall S.A. (Spain) Antihistamine Drugs Business SWOT Analysis and Forecast
        5.2.4 Almirall S.A. (Spain) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
    5.3 Auctus Pharma Limited (India)
        5.3.1 Auctus Pharma Limited (India) Company Details and Competitors
        5.3.2 Auctus Pharma Limited (India) Key Antihistamine Drugs Models and Performance
        5.3.3 Auctus Pharma Limited (India) Antihistamine Drugs Business SWOT Analysis and Forecast
        5.3.4 Auctus Pharma Limited (India) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
    5.4 Bayer SA-NV (Belgium)
        5.4.1 Bayer SA-NV (Belgium) Company Details and Competitors
        5.4.2 Bayer SA-NV (Belgium) Key Antihistamine Drugs Models and Performance
        5.4.3 Bayer SA-NV (Belgium) Antihistamine Drugs Business SWOT Analysis and Forecast
        5.4.4 Bayer SA-NV (Belgium) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
    5.5 Kyowa Hakko Kirin Co.,Ltd. (Japan)
        5.5.1 Kyowa Hakko Kirin Co.,Ltd. (Japan) Company Details and Competitors
        5.5.2 Kyowa Hakko Kirin Co.,Ltd. (Japan) Key Antihistamine Drugs Models and Performance
        5.5.3 Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Business SWOT Analysis and Forecast
        5.5.4 Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
    5.6 MEDA Pharma GmbH & Co. KG (Germany)
        5.6.1 MEDA Pharma GmbH & Co. KG (Germany) Company Details and Competitors
        5.6.2 MEDA Pharma GmbH & Co. KG (Germany) Key Antihistamine Drugs Models and Performance
        5.6.3 MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Business SWOT Analysis and Forecast
        5.6.4 MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
    5.7 Merck Sharp & Dohme Limited (UK)
        5.7.1 Merck Sharp & Dohme Limited (UK) Company Details and Competitors
        5.7.2 Merck Sharp & Dohme Limited (UK) Key Antihistamine Drugs Models and Performance
        5.7.3 Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Business SWOT Analysis and Forecast
        5.7.4 Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
    5.8 Nippon Boehringer Ingelheim Co.,Ltd. (Japan)
        5.8.1 Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Company Details and Competitors
        5.8.2 Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Key Antihistamine Drugs Models and Performance
        5.8.3 Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Business SWOT Analysis and Forecast
        5.8.4 Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
    5.9 Pfizer Pharmaceutical Company (US)
        5.9.1 Pfizer Pharmaceutical Company (US) Company Details and Competitors
        5.9.2 Pfizer Pharmaceutical Company (US) Key Antihistamine Drugs Models and Performance
        5.9.3 Pfizer Pharmaceutical Company (US) Antihistamine Drugs Business SWOT Analysis and Forecast
        5.9.4 Pfizer Pharmaceutical Company (US) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
    5.10 Sanofi Winthrop Industries (France)
        5.10.1 Sanofi Winthrop Industries (France) Company Details and Competitors
        5.10.2 Sanofi Winthrop Industries (France) Key Antihistamine Drugs Models and Performance
        5.10.3 Sanofi Winthrop Industries (France) Antihistamine Drugs Business SWOT Analysis and Forecast
        5.10.4 Sanofi Winthrop Industries (France) Antihistamine Drugs Sales Volume Revenue Price Cost and Gross Margin
    5.11 Santen Pharmaceutical Co.,Ltd. (Japan)
    5.12 Schering-Plough Europe (US)
    5.13 Sun Pharmaceutical Industries Ltd. (India)
    5.14 Teva Pharmaceutical Industries (Israel)
    5.15 Therabel Europe Limited (Ireland)
    5.16 UCB Pharma GmbH (Germany)
    5.17 Vintage Pharmaceuticals (US)

Chapter Six Industry Chain and Supply Chain
    6.1 Antihistamine Drugs Industry Chain Structure
        6.1.1 R&D
        6.1.2 Raw Materials (Components)
        6.1.3 Manufacturing Plants
        6.1.4 Regional Trading (Import Export and Local Sales)
        6.1.5 Online Sales Channel
        6.1.6 Offline Channel
        6.1.7 End Users
    6.2 Antihistamine Drugs Manufacturing
        6.2.1 Key Components
        6.2.2 Assembly Manufacturing
    6.3 Consumer Preference
    6.4 Behavioral Habits
    6.5 Marketing Environment

Chapter Seven Global Antihistamine Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    7.1 Global Antihistamine Drugs Sales (Million Units), Revenue (Million USD) Forecast (2017-2022)
    7.2 Global Antihistamine Drugs Sales (Million Units) Forecast by Regions (2017-2022)
    7.3 Global Antihistamine Drugs Sales (Million Units) Forecast by Application (2017-2022)
    7.4 Global Antihistamine Drugs Sales (Million Units) Forecast by Antihistanmines (2017-2022)
    7.5 Global Antihistamine Drugs Sales (Million Units) Forecast by Access (2017-2022)

Chapter Eight Development Trend and Research Conclusion
    8.1 Development Trend
    8.2 Research Conclusion

Chapter Nine Methodology and Data Source
    9.1 Methodology/Research Approach
        9.1.1 Research Programs/Design
        9.1.2 Market Size Estimation
        9.1.3 Market Breakdown and Data Triangulation
    9.2 Data Source
        9.2.1 Secondary Sources
        9.2.2 Primary Sources
    9.3 Disclaimer



                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)3250 View Pricing